Natural Alternatives International announced that it has received New Dietary Ingredient, or NDI, status from the FDA for its patented CarnoSyn beta-alanine ingredient at a total daily intake level of 6.4 grams per day. NAI received the FDA’s Acknowledgement Without Objection or AKL letter within its statutory 75-day evaluation period to respond. It has been assigned NDI report number 1103. CarnoSyn is the only beta-alanine that has successfully obtained NDI status with the FDA.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.